Rchr
J-GLOBAL ID:202101008779176600   Update date: Feb. 27, 2024

Wada Akira

ワダ アキラ | Wada Akira
Affiliation and department:
Research field  (3): Molecular biochemistry ,  Functional biochemistry ,  Parasitology
Research keywords  (5): Metal Complex ,  Peptide ,  Drug Discovery ,  Infectious Diseases ,  がん
Research theme for competitive and other funds  (8):
  • 2018 - 2021 The metal element targeting method that enables to the expression of growth inhibitory effects against pathogenic protozoa, and the analyses on their mode-of-actions
  • 2014 - 2017 Development of anti-infective agents focusing on intracellular changes in metal concentration
  • 2012 - 2015 Development of a chemical biosensing technology for exploring bioactive compounds
  • 2011 - 2012 Development of a novel methodology for exploration of peptides that induce cell differentiations
  • 2010 - 2010 新規リボソーム・ディスプレイ法の開発と非天然型ペプチド阻害剤の創出
Show all
Papers (34):
  • Takayuki Shinohara, Akira Wada, Masahiro Abe, Nobuko Nakayama, Minoru Nagi, Yoshitsugu Miyazaki. A Novel Zinc-Chelating Compound Has Antifungal Activity Against a Wide Range of Candida Species, Including Multidrug-Resistant Candida auris. JAC-Antimicrob. Resist. 2024. 6,. dlad155.
  • Takuto Furuhashi, Kensaku Sakamoto, Akira Wada. Genetic Code Expansion and a Photo-Cross-Linking Reaction Facilitate Ribosome Display Selections for Identifying a Wide Range of Affinity Peptides. Int. J. Mol. Sci. 2023. 24,. 15661.
  • Hiroko Asahi, Mamoru Niikura, Shin-Ichi Inoue, Fujiro Sendo, Fumie Kobayashi, Akira Wada. Dihydroartemisinin Disrupts Zinc Homeostasis in Plasmodium falciparum to Potentiate Its Antimalarial Action via Pyknosis. ACS Infectious Diseases. 2023. 9,. 1303.
  • Akira Wada, Yuko Umeki, Takeshi Annoura, Yumiko Saito-Nakano. In Vitro and In Vivo Antiamebic Activity of Iron-Targeting Polypyridine Compounds against Enteric Protozoan Parasite Entamoeba histolytica. ACS Infectious Diseases. 2022. 8,. 457.
  • Akira Wada. Ribosome Display Technology for Selecting Peptide and Protein Ligands. Biomed. Appl. Funct. Nanomat. 2018. C4,. 89.
more...
MISC (8):
  • 和田 章. 生命分子を人工的にデザイン. RIKEN BDR Times「いきもんタイムズ」. 2021. 3
  • Akira Wada, Naoki Kato, Slava Ziegler. Joint Knowledge and Technology for Systems Chemical Biology. ChemBioChem. 2013. 14,. 1504.
  • 和田 章, 阿部 洋, 伊藤 嘉浩. アプタマー医薬. 抗体医薬の最前線 (普及版). 2013. 19章
  • 和田 章. ペプチド・バイオテクノロジーを切り拓く研究者. RIKEN NEWS. 2011. 356
  • 増田 秀樹, 和田 章, 鈴木 正樹. 金属錯体による活性酸素の補足と反応性を制御する. 化学フロンティア16:チャンピオンレコードをもつ金属錯体最前線. 2006. 10章
more...
Patents (9):
  • 赤痢アメーバ治療薬
  • Anti-malarial agent
  • Nucleic acid construction, nucleic acid-protein complex and use thereof
  • 標的物質検出用核酸プローブ
  • 核酸構築物、核酸-蛋白質複合体及びその利用
more...
Professional career (1):
  • 博士 (工学)
Work history (1):
  • 2018/04 - 現在 RIKEN
Awards (1):
  • 2014 - The RIKEN Research Incentive Award
Association Membership(s) (5):
日本ケミカルバイオロジー学会 ,  日本分子生物学会 ,  日本寄生虫学会 ,  錯体化学会 ,  日本化学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page